JPRN-jRCTs051180147已完成未知
FLT-PET/MRI imaging for the evaluation of early response to immune checkpoint inhibitors - FLT-PET/MRI imaging for the immune checkpoint inhibitors
meda Yukihiro0 个研究点目标入组 26 人开始时间: 2019年3月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
This prospective study showed that changes in TLP measured by 18F-FLT PET as early as 2 weeks after treatment initiation could have utility as predictors of the response and progression-free survival of NSCLC patients treated with anti-PD-1 antibody therapy.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Age 20 or over.
- •2) Patients with pathologically confirmed advanced non-small cell lung cancer (NSCLC), and indication of PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab).
- •3) Written informed consent.
排除标准
- •1) Patients with metallic device in their body.
- •2) Patients with claustrophobia.
- •3) Pregnant or lactating woman.
- •4) Other cases attending physician it is determined unsuitable for registration of the study.
研究者
相似试验
已完成
不适用
FLT-PET/MRI imaging for the evaluation of early response to immune checkpoint inhibitorson-small cell lung cancerJPRN-UMIN000027460Third department of internal medicine, Universtiy of Fukui26
已完成
不适用
FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic AgentsUnspecified Adult Solid Tumor, Protocol SpecificNCT02055586Case Comprehensive Cancer Center10
已完成
2 期
Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic AdenocarcinomaPancreatic AdenocarcinomaNCT03318497University of Texas Southwestern Medical Center6
Unknown
不适用
A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix CancerImage, BodyCervix CancerNCT05355558National Cancer Centre, Singapore15
撤回
早期 1 期
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid TumorsSolid TumorNCT03905538University of Texas Southwestern Medical Center